GSK investigational vaccine GSK2340269A

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Influenza

Phase 2

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

CompletedNCT00951041

GlaxoSmithKlineInfluenza

Start: 2009-08-11End: 2010-08-30Updated: 2018-11-26

Phase 3

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

CompletedNCT00968539

GlaxoSmithKlineInfluenza

Start: 2009-09-08End: 2010-09-28Updated: 2019-11-18

Related Papers

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials

Clinical and Vaccine Immunology2017-04-2718 citations